HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jingjing Wang Selected Research

sanguinarine

11/2021Sanguinarine impairs lysosomal function and induces ROS-dependent mitophagy and apoptosis in human hepatocellular carcinoma cells.
4/2021Sanguinarine impedes metastasis and causes inversion of epithelial to mesenchymal transition in breast cancer.
4/2021Sanguinarine combats hypoxia-induced activation of EphB4 and HIF-1α pathways in breast cancer.
8/2020Blocking Parkin/PINK1-mediated mitophagy sensitizes hepatocellular carcinoma cells to sanguinarine-induced mitochondrial apoptosis.
1/2020Sanguinarine disrupts the colocalization and interaction of HIF-1α with tyrosine and serine phosphorylated-STAT3 in breast cancer.
12/2019Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jingjing Wang Research Topics

Disease

119Neoplasms (Cancer)
08/2022 - 01/2005
51Infections
06/2022 - 08/2008
37Inflammation (Inflammations)
06/2022 - 08/2012
18Hypoxia (Hypoxemia)
02/2022 - 05/2014
18Asthma (Bronchial Asthma)
11/2021 - 03/2015
15Virus Diseases (Viral Diseases)
01/2022 - 08/2008
14Neoplasm Metastasis (Metastasis)
04/2021 - 11/2017
13Hepatocellular Carcinoma (Hepatoma)
11/2021 - 12/2015
11Nasopharyngeal Carcinoma
10/2021 - 08/2017
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2021 - 03/2016
9Melanoma (Melanoma, Malignant)
06/2022 - 01/2014
9Fibrosis (Cirrhosis)
05/2022 - 05/2013
9Breast Neoplasms (Breast Cancer)
02/2022 - 07/2017
9Wounds and Injuries (Trauma)
07/2021 - 04/2016
8Carcinoma (Carcinomatosis)
06/2022 - 05/2014
8Mitochondrial Diseases (Mitochondrial Disease)
02/2022 - 06/2015
8Pneumonia (Pneumonitis)
05/2021 - 01/2019
8Mastitis
12/2020 - 09/2015
8Hypertrophy
01/2020 - 01/2013
7Colorectal Neoplasms (Colorectal Cancer)
08/2022 - 01/2014
7Proteinuria
01/2022 - 01/2013
7Lung Neoplasms (Lung Cancer)
01/2022 - 01/2018
7Multiple Myeloma
01/2022 - 10/2015
7Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 11/2017
6Sepsis (Septicemia)
05/2022 - 01/2019
6Carcinogenesis
01/2022 - 01/2014
6Hemorrhage
04/2021 - 09/2014
6Disease Progression
03/2021 - 06/2014
6Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 12/2014
6Type 2 Diabetes Mellitus (MODY)
11/2020 - 07/2015
6Insulin Resistance
11/2020 - 01/2013
5Myopia
11/2022 - 01/2020
5Body Weight (Weight, Body)
05/2022 - 10/2014
5Angiofibroma
01/2022 - 08/2014
5Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2013
5Ulcerative Colitis
01/2022 - 07/2016
5Glioma (Gliomas)
11/2021 - 07/2007
5Nephrotic Syndrome (Syndrome, Nephrotic)
09/2021 - 01/2015
5Necrosis
01/2019 - 07/2016
4Hypersensitivity (Allergy)
04/2022 - 08/2008
4Brain Neoplasms (Brain Tumor)
01/2022 - 07/2007

Drug/Important Bio-Agent (IBA)

50Proteins (Proteins, Gene)FDA Link
05/2022 - 06/2012
28Pharmaceutical PreparationsIBA
05/2022 - 01/2012
24CytokinesIBA
01/2022 - 08/2008
19Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2007
14Peptides (Polypeptides)IBA
08/2022 - 03/2016
14Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2015
13Cisplatin (Platino)FDA LinkGeneric
05/2022 - 06/2012
12LipopolysaccharidesIBA
06/2022 - 01/2015
12Antiviral Agents (Antivirals)IBA
06/2022 - 11/2012
12VaccinesIBA
12/2021 - 08/2008
11MicroRNAs (MicroRNA)IBA
05/2022 - 04/2013
11AntigensIBA
11/2021 - 02/2014
10Long Noncoding RNAIBA
05/2022 - 01/2018
9Messenger RNA (mRNA)IBA
03/2022 - 01/2007
9InterferonsIBA
01/2022 - 08/2015
9Biological ProductsIBA
11/2021 - 06/2014
9Transcription Factors (Transcription Factor)IBA
01/2021 - 05/2013
9Interleukin-17 (Interleukin 17)IBA
01/2019 - 01/2014
8RNA (Ribonucleic Acid)IBA
05/2022 - 01/2016
8Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 06/2015
8Interleukin-33IBA
11/2021 - 08/2015
8LipidsIBA
01/2020 - 01/2013
7Therapeutic UsesIBA
01/2022 - 01/2007
7CollagenIBA
01/2020 - 08/2012
6Indicators and Reagents (Reagents)IBA
05/2022 - 10/2012
6Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
6sanguinarineIBA
11/2021 - 12/2019
6PlatinumIBA
02/2021 - 03/2018
6SteroidsIBA
01/2021 - 01/2015
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2020 - 02/2008
6Insulin (Novolin)FDA Link
11/2020 - 01/2013
6InterleukinsIBA
01/2017 - 09/2015
5DNA (Deoxyribonucleic Acid)IBA
04/2022 - 09/2017
5EnzymesIBA
01/2022 - 07/2016
5Viral RNAIBA
01/2022 - 01/2014
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2021 - 01/2007
5Transforming Growth Factors (Transforming Growth Factor)IBA
11/2021 - 08/2017
5Peroxidase (Myeloperoxidase)IBA
04/2021 - 09/2015
5Interleukin-6 (Interleukin 6)IBA
01/2021 - 02/2008
5atezolizumabIBA
01/2021 - 03/2018
5AntibodiesIBA
01/2020 - 07/2007
5Phosphotransferases (Kinase)IBA
01/2020 - 01/2018
4Fluorescent Dyes (Fluorescent Probes)IBA
05/2022 - 07/2007
4Folic Acid (Vitamin M)FDA LinkGeneric
04/2022 - 10/2018
4Estrogen ReceptorsIBA
02/2022 - 01/2015
4MelatoninIBA
01/2022 - 11/2015
4MonocrotalineIBA
01/2022 - 01/2018
4Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 09/2020

Therapy/Procedure

60Therapeutics
02/2022 - 07/2007
28Drug Therapy (Chemotherapy)
05/2022 - 03/2011
21Radiotherapy
06/2022 - 06/2014
15Immunotherapy
08/2022 - 04/2015
8Lasers (Laser)
10/2021 - 01/2012
7Chemoradiotherapy
01/2021 - 01/2018
7Precision Medicine
12/2019 - 09/2017
6Photochemotherapy (Photodynamic Therapy)
09/2020 - 04/2015
5Induction Chemotherapy
01/2021 - 03/2019
4Intravenous Injections
08/2022 - 03/2016
4Neoadjuvant Therapy
04/2022 - 02/2018